Skip to main content
Erschienen in: Supportive Care in Cancer 1/2014

01.01.2014 | Original Article

Education for cancer-related fatigue: could talking about it make people more likely to report it?

verfasst von: Lisa O’Brien, Anna Loughnan, Amanda Purcell, Terry Haines

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Education-based interventions for cancer-related fatigue have shown promise in adults undergoing radiotherapy. Research on the cancer-related fatigue intervention trial (CAN-FIT) programme found that pre-radiotherapy fatigue information and support (pre-RFES) did not improve levels of fatigue, but was associated with improvements in activity-based outcomes. We aimed to measure whether pre-RFES resulted in greater participant self-ratings of their performance of daily living activities, fatigue, quality of life and distress.

Methods

Thirty people undergoing radiotherapy and/or chemotherapy were randomly allocated to either a 1-h RFES session from the CAN-FIT programme (delivered individually to participants and modified where necessary for patients undergoing chemotherapy) or standard care. Measures were taken pre- and post-treatment and 6 weeks after completing treatment.

Results

There was no significant difference between groups on performance of daily living activities or ratings of distress. Further analysis found a significant difference between the control and treatment groups for EQ-5D health state visual analogue scale (−9.05 [−18.09; −0.018]; p < 0.05) and physical fatigue (2.86 [0.58; 5.14]; p < 0.02) with the treatment group rating their overall health state worse and their physical fatigue higher than the controls.

Conclusions

Pre-RFES delivered individually did not significantly improve participants’ ratings of their performance of daily occupations and was unexpectedly associated with worse overall health state and higher physical fatigue. Future trials, ideally comparing individual and group education to exercise programmes or cognitive–behavioural approaches, are recommended to examine the broader question of whether discussing fatigue might actually make participants feel worse.
Literatur
1.
Zurück zum Zitat Hofman M et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Supplement 1):4–10PubMedCrossRef Hofman M et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Supplement 1):4–10PubMedCrossRef
2.
Zurück zum Zitat Purcell A et al (2010) A multidimensional examination of correlates of fatigue during radiotherapy. Cancer 116(2):529–537PubMedCrossRef Purcell A et al (2010) A multidimensional examination of correlates of fatigue during radiotherapy. Cancer 116(2):529–537PubMedCrossRef
3.
Zurück zum Zitat Chow E et al (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol (R Coll Radiol) 20(1):76–82CrossRef Chow E et al (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol (R Coll Radiol) 20(1):76–82CrossRef
4.
Zurück zum Zitat Hickok JT et al (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manag 30(5):433–442CrossRef Hickok JT et al (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manag 30(5):433–442CrossRef
5.
Zurück zum Zitat Ahlberg K, Ekman T, Gaston-Johansson F (2005) The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer. Int J Nurs Stud 42(4):377–386PubMedCrossRef Ahlberg K, Ekman T, Gaston-Johansson F (2005) The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer. Int J Nurs Stud 42(4):377–386PubMedCrossRef
6.
Zurück zum Zitat de Jong N et al (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25(4):283–297PubMedCrossRef de Jong N et al (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25(4):283–297PubMedCrossRef
7.
Zurück zum Zitat Hird A et al (2010) Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index. Supportive Care Cancer 18(3):335–342CrossRef Hird A et al (2010) Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index. Supportive Care Cancer 18(3):335–342CrossRef
8.
Zurück zum Zitat Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50(5):440–447PubMed Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50(5):440–447PubMed
9.
Zurück zum Zitat Jacobsen P, Weitzner M (2004) Fatigue and depression in cancer patients: conceptual and clinical issues. Fatigue in cancer. Oxford Univ Press, Oxford, pp 223–241 Jacobsen P, Weitzner M (2004) Fatigue and depression in cancer patients: conceptual and clinical issues. Fatigue in cancer. Oxford Univ Press, Oxford, pp 223–241
10.
Zurück zum Zitat Kangas M, Bovbjerg DH, Montgomery GH (2008) Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134(5):700PubMedCrossRef Kangas M, Bovbjerg DH, Montgomery GH (2008) Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134(5):700PubMedCrossRef
11.
Zurück zum Zitat Multiple Risk Factor Intervention Trial (1997) Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 277(7):582–594CrossRef Multiple Risk Factor Intervention Trial (1997) Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 277(7):582–594CrossRef
12.
Zurück zum Zitat Hickok J et al (2005) Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8):1772–1778PubMedCrossRef Hickok J et al (2005) Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8):1772–1778PubMedCrossRef
13.
Zurück zum Zitat Barsevick A, Dudley W, Beck S (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef Barsevick A, Dudley W, Beck S (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef
14.
Zurück zum Zitat Mock V (2004) Evidence-based treatment for cancer-related fatigue. JNCI Monogr 2004(32):112–118CrossRef Mock V (2004) Evidence-based treatment for cancer-related fatigue. JNCI Monogr 2004(32):112–118CrossRef
15.
16.
Zurück zum Zitat Purcell A et al (2010) Development of an educational intervention for cancer-related fatigue. Br J Occup Ther 73(7):327–333CrossRef Purcell A et al (2010) Development of an educational intervention for cancer-related fatigue. Br J Occup Ther 73(7):327–333CrossRef
17.
Zurück zum Zitat Purcell A et al (2011) Is education an effective management strategy for reducing cancer-related fatigue? Support Care Cancer 19(9):1429–1439PubMedCrossRef Purcell A et al (2011) Is education an effective management strategy for reducing cancer-related fatigue? Support Care Cancer 19(9):1429–1439PubMedCrossRef
18.
Zurück zum Zitat Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–656PubMedCrossRef Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–656PubMedCrossRef
19.
Zurück zum Zitat Baron K et al (2006) A user’s manual for the occupational self-assessment (version 2.2). University of Illinois, Chicago Baron K et al (2006) A user’s manual for the occupational self-assessment (version 2.2). University of Illinois, Chicago
20.
Zurück zum Zitat Kielhofner G et al (2009) Developing the occupational self assessment: the use of Rasch analysis to assure internal validity, sensitivity and reliability. Br J Occup Ther 72(3):94–104 Kielhofner G et al (2009) Developing the occupational self assessment: the use of Rasch analysis to assure internal validity, sensitivity and reliability. Br J Occup Ther 72(3):94–104
21.
Zurück zum Zitat Smets E et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325PubMedCrossRef Smets E et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325PubMedCrossRef
22.
Zurück zum Zitat Purcell A et al (2010) Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer 18(3):307–315PubMedCrossRef Purcell A et al (2010) Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer 18(3):307–315PubMedCrossRef
23.
Zurück zum Zitat Dolan P, Roberts J (2002) Modelling valuations for EQ-5D health states: an alternative model using differences in valuations. Med Care 40(5):442–446PubMedCrossRef Dolan P, Roberts J (2002) Modelling valuations for EQ-5D health states: an alternative model using differences in valuations. Med Care 40(5):442–446PubMedCrossRef
24.
Zurück zum Zitat National Comprehensive Cancer Network (2003) Distress management clinical practice guidelines. J Natl Comp Cancer Netw 1:344–374 National Comprehensive Cancer Network (2003) Distress management clinical practice guidelines. J Natl Comp Cancer Netw 1:344–374
25.
Zurück zum Zitat Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Nat Cancer Inst 101(21):1464–1488PubMedCrossRef Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Nat Cancer Inst 101(21):1464–1488PubMedCrossRef
26.
Zurück zum Zitat Ransom S, Jacobsen PB, Booth–Jones M (2006) Validation of the Distress Thermometer with bone marrow transplant patients. Psychol–Oncol 15(7):604–612CrossRef Ransom S, Jacobsen PB, Booth–Jones M (2006) Validation of the Distress Thermometer with bone marrow transplant patients. Psychol–Oncol 15(7):604–612CrossRef
27.
Zurück zum Zitat Twisk JW (2004) Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 19(8):769–776PubMedCrossRef Twisk JW (2004) Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 19(8):769–776PubMedCrossRef
28.
Zurück zum Zitat Pickard AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5:70PubMedCrossRef Pickard AS, Neary MP, Cella D (2007) Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 5:70PubMedCrossRef
29.
Zurück zum Zitat Prue G et al (2006) Cancer-related fatigue: a critical appraisal. Eur J Cancer 42(7):846–863PubMedCrossRef Prue G et al (2006) Cancer-related fatigue: a critical appraisal. Eur J Cancer 42(7):846–863PubMedCrossRef
30.
Zurück zum Zitat Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38(1):27–43PubMedCrossRef Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38(1):27–43PubMedCrossRef
31.
Zurück zum Zitat Wee CC et al (2013) Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery. JAMA Surg 148(3):264–271PubMedCrossRef Wee CC et al (2013) Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery. JAMA Surg 148(3):264–271PubMedCrossRef
32.
Zurück zum Zitat Linde K et al (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128(3):264–271PubMedCrossRef Linde K et al (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128(3):264–271PubMedCrossRef
33.
Zurück zum Zitat McPhail S, Haines T (2010) The response shift phenomenon in clinical trials. J Clin Res Best Pract 6(2):1–8 McPhail S, Haines T (2010) The response shift phenomenon in clinical trials. J Clin Res Best Pract 6(2):1–8
Metadaten
Titel
Education for cancer-related fatigue: could talking about it make people more likely to report it?
verfasst von
Lisa O’Brien
Anna Loughnan
Amanda Purcell
Terry Haines
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1964-7

Weitere Artikel der Ausgabe 1/2014

Supportive Care in Cancer 1/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.